Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014743 |
| CAS No | NA |
| Mol.F. | C24H29N3O4 |
| Mol.Wt. | 423.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014744 |
| CAS No | NA |
| Mol.F. | C31H33N3O4 |
| Mol.Wt. | 511.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014745 |
| CAS No | 937-23-5 |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.04 |
| INV STATUS | In Stock |
| CAT No | SRC-N014746 |
| CAS No | NA |
| Mol.F. | C20H22FN5O3 |
| Mol.Wt. | 399.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014747 |
| CAS No | NA |
| Mol.F. | C18H27N3O5 |
| Mol.Wt. | 365.42 |
| INV STATUS | In Stock |
| CAT No | SRC-N014748 |
| CAS No | NA |
| Mol.F. | C22H21N7O2 |
| Mol.Wt. | 415.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014749 |
| CAS No | NA |
| Mol.F. | CH3N3O2 |
| Mol.Wt. | 89.05 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014750 |
| CAS No | NA |
| Mol.F. | C20H18D3N9O4 |
| Mol.Wt. | 454.47 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014751 |
| CAS No | NA |
| Mol.F. | C21H31Cl2N5O2 |
| Mol.Wt. | 456.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014752 |
| CAS No | NA |
| Mol.F. | C20H24N2O2 |
| Mol.Wt. | 324.40 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014753 |
| CAS No | NA |
| Mol.F. | C36H40N4O7 |
| Mol.Wt. | 640.7 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014754 |
| CAS No | NA |
| Mol.F. | C14H10N2O2 |
| Mol.Wt. | 238.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014755 |
| CAS No | NA |
| Mol.F. | C15H12N2O2 |
| Mol.Wt. | 252.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014756 |
| CAS No | NA |
| Mol.F. | C14H8N2O3 |
| Mol.Wt. | 252.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014757 |
| CAS No | NA |
| Mol.F. | C24H26N6O3 |
| Mol.Wt. | 446.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014758 |
| CAS No | NA |
| Mol.F. | C24H26N6O3 |
| Mol.Wt. | 446.5 |
| INV STATUS | UNDER SYNTHESIS |